A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)
Clinical trial NCT01877655 · COMPLETED
Trial details
- NCT number
- NCT01877655
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-11
- Primary completion
- 2017-09-28
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.